ALLO
Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Allogene Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0.
- Allogene Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Allogene Therapeutics Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Allogene Therapeutics Inc. annual revenue for 2024 was 22000, a 76.84% decrease from 2023.
- Allogene Therapeutics Inc. annual revenue for 2023 was 95000, a 39.10% decrease from 2022.
- Allogene Therapeutics Inc. annual revenue for 2022 was 156000.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Allogene Therapeutics Inc. Earnings — FAQ
Allogene Therapeutics Inc. (ALLO) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's earnings history?
The chart and table above show Allogene Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.